Now live: Pro — the full 13F research suite for serious investorsSee pricing →
BAIN CAPITAL INVESTORS LLC

Q4 2024 · 13F-HR

BAIN CAPITAL INVESTORS LLCholdings as filed

Filed 2025-02-14 · accession 0000950123-25-002718

$3.50B
Reported value
5
Positions
2024-12-31
Period end
View analyzed profile →PRO

The Brief · BAIN CAPITAL INVESTORS LLC · Q4 2024

AI · grounded in 13F

BAIN CAPITAL INVESTORS LLC reported no changes to its 13F holdings for 2024-12-31 relative to 2024-09-30.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
86881A100SGRYSURGERY PARTNERS INC$1.06B30.2%49,946,972CommonSOLE
67059N108NTNXNUTANIX INC$1.03B29.5%16,854,032CommonSOLE
946784105WAYWAYSTAR HLDG CORP$1.03B29.4%27,980,417CommonSOLE
05356F105AVAHAVEANNA HEALTHCARE HLDGS INC$372.9M10.7%81,600,880CommonSOLE
00791N102ADVANTAGE SOLUTIONS INC$8.4M0.24%2,890,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.